Abstract
In the past 10 to 15 years, a considerable progress has been made in the treatment of gastrointestinal (GI) related malignancies, as a number of agents expanded from only one in 1995 to seven in 2006. Current review describes the recent role of targeted therapies, specifically EGFR inhibitors in the treatment of GI cancers. Importance of dietary agents in the treatment and prevention of GI cancers is also reviewed.
Keywords: EGFR inhibitors, colon cancer, apoptosis
Current Drug Targets
Title: EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: Whats New?
Volume: 11 Issue: 6
Author(s): Shailender Singh Kanwar, Jyoti Nautiyal and Adhip P.N. Majumdar
Affiliation:
Keywords: EGFR inhibitors, colon cancer, apoptosis
Abstract: In the past 10 to 15 years, a considerable progress has been made in the treatment of gastrointestinal (GI) related malignancies, as a number of agents expanded from only one in 1995 to seven in 2006. Current review describes the recent role of targeted therapies, specifically EGFR inhibitors in the treatment of GI cancers. Importance of dietary agents in the treatment and prevention of GI cancers is also reviewed.
Export Options
About this article
Cite this article as:
Singh Kanwar Shailender, Nautiyal Jyoti and P.N. Majumdar Adhip, EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: Whats New?, Current Drug Targets 2010; 11 (6) . https://dx.doi.org/10.2174/138945010791170851
DOI https://dx.doi.org/10.2174/138945010791170851 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanomedicines as Cancer Therapeutics: Current Status
Current Cancer Drug Targets Dendritic Cell Immunotherapy for Melanoma
Reviews on Recent Clinical Trials Organophosphorus Compounds: Intervention in Mechanisms of Signal Transduction Relevant to Proliferative, Immunological and Circulatory Disorders
Current Medicinal Chemistry The Antitumor Effects of Icaritin Against Breast Cancer is Related to Estrogen Receptors
Current Molecular Medicine Improvement of Tumor Localization of Photosensitizers for Photodynamic Therapy and Its Application for Tumor Diagnosis
Current Topics in Medicinal Chemistry Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)
Current Pharmaceutical Biotechnology The Genetic Landscapes of Inflammation-Driven Gastrointestinal Tract Cancers
Current Pharmaceutical Design Potential Utilization of Bystander / Abscopal-Mediated Signal Transduction Events in the Treatment of Solid Tumors
Current Signal Transduction Therapy A Review on Recent Developments in Positron Emission Tomography Technology
Recent Patents on Medical Imaging Interleukin-15 in Gene Therapy of Cancer
Current Gene Therapy Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
Current Cancer Drug Targets Resveratrol and Its Analogues: Promising Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Insights Into Effects of Ellagic Acid on the Nervous System: A Mini Review
Current Pharmaceutical Design Hydatid Disease: Current Status of Chemotherapy and Drug Delivery Systems
Current Drug Therapy Imaging with Raman Spectroscopy
Current Pharmaceutical Biotechnology Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Recent Patents on CNS Drug Discovery (Discontinued) Pleiotropic Effects of Cardioactive Glycosides
Current Medicinal Chemistry Psychoimmunological Analysis of Cancer Patients: Correlation with the Prognosis
Current Aging Science Tumor Dormancy and the Angiogenic Switch: Possible Implications of Bone Marrow- Derived Cells
Current Pharmaceutical Design Directing Hypoxic Tumor Microenvironment and HIF to Illuminate Cancer Immunotherapy's Existing Prospects and Challenges in Drug Targets
Current Drug Targets